Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples